Overview

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin